Led · Seed · Jul 2026

Tyred builds a connected bike ownership platform that combines IoT sensors, AI-driven predictive maintenance and operational data with bundled services such as servicing, insurance, warranties and finance. The company began in 2022 as a mobile bike repair service and has since expanded into fleet and consumer offerings. Tyred says it has serviced more than 100,000 bicycles over the past year and maintains around 50,000 Lime bikes in London, building a dataset to power its predictive models. Its product aims to flag wear or degrading components before failures occur, reducing reactive repairs for riders and fleet operators. With the new capital the company plans to hire engineering talent, develop its product further and expand across the UK and into European markets. Tyred positions itself as a single dashboard for fragmented ownership services to keep more bikes on the road and simplify ownership.

Participated · Seed · Jun 2026

Idilio produces vertical micronovelas with episodes of one to three minutes and seasons that can reach up to 80 chapters, aiming for strong hooks in the first three seconds. The company describes itself as data-first: it writes and produces initial chapters, publishes them in-app and on social, and uses rapid metrics to decide whether to rewrite or scale a story. Idilio reports roughly two million downloads in 120 countries and about 45 minutes of daily use per user, which the company says is double Netflix's mobile time by its metrics. Founder Gabriela Tafur, a Colombian lawyer, TV presenter and Stanford MBA, built the product after observing short-form dubbed dramas in mobile use. The company targets Latin American melodrama as a cultural differentiator versus Chinese-origin micro-series and aims to scale its audience internationally. The model emphasizes low-cost, fast production cycles but faces sector risks such as low retention and variable content quality.

Participated · Equity · May 2026

iFAST Diagnostics is developing the iFAST One, an ultra-rapid antimicrobial susceptibility test system that leverages impedance flow cytometry to measure electrical properties of bacteria from positive blood culture samples. The platform can provide AST results in less than three hours and is priced comparably to the standard of care. The company received the UK Conformity Assessed (UKCA) mark for the system earlier this year. To support commercialization, iFAST closed a £5 million financing round and obtained a £2.1 million non-dilutive loan from Innovate UK. The new funding is earmarked to expand UK rollout, pursue EU regulatory approval, and accelerate regulatory and clinical programs in the US.

Participated · Series A · Apr 2026

Comfi is a startup that provides capital solutions for small and medium-sized enterprises in the MENA region. The company announced a US$65 million Pre-Series A raise to expand and scale its SME capital operations across the region. Public reporting did not disclose detailed operating metrics, prior funding history, or valuation. Comfi plans to deploy the new funding to grow its lending or capital-provision capabilities and expand its regional footprint. No additional financial details or investor names were disclosed in the articles.

Led · Series A · Jan 2025

Fermata develops computer-vision software that analyzes twice-daily images from any off-the-shelf camera to diagnose diseases and pest infestations in greenhouse crops and send alerts to farmers via an app. The company keeps its data-labeling team in-house and operates an R&D center where it deliberately infects plants to generate training data, which the founder attributes to higher model accuracy. Fermata has focused initially on greenhouse-grown tomatoes and has deployed more than 100 cameras to date. It sells directly to farms and also partners with large agriculture companies such as Bayer and Syngenta. The team plans to expand into additional crops and grow its partnership network. Fermata aims to scale the business and reach profitability by 2026. Fermata is described in the article as an Israeli‑Russian developer of technologies for monitoring the condition of plants. The company develops tools to monitor plant health and crop condition. The vc.ru report states Fermata raised $3.7 million. The article does not provide details on the financing instrument, investors, valuation, or use of proceeds. Commenters on the article suggested potential applications including monitoring greens, potatoes, tomatoes, and cucumbers. One commenter noted Fermata’s website is only in English and suggested it may not be targeting Russia. No operating metrics or explicit future plans were included in the report.